Materialise NV: Materialise Reports Second Quarter and Half-Year 2026 Results

Materialise NV reported Q2 2026 revenue of 70,073 kEUR, up 8.1% YoY. Adjusted EBITDA rose 15.7% to 9,593 kEUR, and net profit increased to 3,331 kEUR. Medical segment revenue grew 12.2%, while Software segment revenue declined 2.7%. H1 2026 revenue was 136,349 kEUR, up 3.9% YoY, with adjusted EBITDA up 22.2% to 17,642 kEUR.

Original reporting
Published Aug 27, 2026, 5:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 6:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$MTLS
Relevance
7/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

Med
01

Why it matters

The earnings beat and strong cash generation suggest potential upside, but mixed segment performance warrants caution.

02

Market read

Earnings release provides fresh data for traders; modest scale but first‑report status makes it actionable.

03

What to watch

Share buyback size and cash position could support near‑term price stability.

Relevance 7/10Novelty 8/10Timing: after-hours release

Background

Materialise NV reported Q2 2026 and six‑month results, highlighting revenue growth, higher EBITDA, and share buybacks.

Market effects

3D printing and medical device sector may see modest uplift from Materialise's improved profitability.

European tech and industrial markets could react positively to the earnings beat.

Limited; primarily impacts European and niche additive‑manufacturing investors.

Counterpoint

Despite earnings beat, the decline in software segment revenue may signal longer‑term headwinds.

Key entities

  • Materialise NV

    European 3D‑printing and medical device firm reporting earnings.

Related articles

$MTLSMed

MATERIALISE NV (MTLS): Financial results for Q2 2026

MATERIALISE NV (MTLS) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Materialise reports second quarter and half-year 2026 results Regulated information 1 LEUVEN, Belgium--(BUSINESS WIRE)—August 27, 2026 -- Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive ma

Med

Aena shares fall as 9-month revenue misses estimates

Aena S.M.E., S.A. reported a 12% YoY net profit increase to €1.77B for the first nine months of 2026, meeting expectations, but revenue of €5.28B missed estimates. Passenger traffic grew 4.1% YoY, exceeding full-year growth estimates. Shares fell 2.2% due to revenue concerns.